Cargando…
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
OBJECTIVES: To assess the therapeutic response to brolucizumab and aflibercept by deep learning/OCT-based analysis of macular fluid volumes in neovascular age-related macular degeneration. METHODS: In this post-hoc analysis of two phase III, randomised, multi-centre studies (HAWK/HARRIER), 1078 and...
Autores principales: | Schmidt-Erfurth, Ursula, Mulyukov, Zufar, Gerendas, Bianca S., Reiter, Gregor S., Lorand, Daniel, Weissgerber, Georges, Bogunović, Hrvoje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101971/ https://www.ncbi.nlm.nih.gov/pubmed/35523860 http://dx.doi.org/10.1038/s41433-022-02077-4 |
Ejemplares similares
-
Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
por: Bogunović, Hrvoje, et al.
Publicado: (2022) -
Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIER
por: Tadayoni, Ramin, et al.
Publicado: (2023) -
Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning
por: Waldstein, Sebastian M., et al.
Publicado: (2017) -
Point-to-point associations of drusen and hyperreflective foci volumes with retinal sensitivity in non-exudative age-related macular degeneration
por: Reiter, Gregor S., et al.
Publicado: (2023) -
Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
por: Lally, David R., et al.
Publicado: (2022)